BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8243609)

  • 1. Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
    Tosi P; Visani G; Ottaviani E; Gamberi B; Cenacchi A; Tura S
    Eur J Haematol; 1993 Oct; 51(4):209-13. PubMed ID: 8243609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
    Tosi P; Visani G; Ottaviani E; Tura S; Darnowski JW
    Eur J Haematol; 1994 May; 52(5):291-5. PubMed ID: 8020629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.
    Darnowski JW; Davol PA; Goulette FA
    Biochem Pharmacol; 1997 Feb; 53(4):571-80. PubMed ID: 9105409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
    Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
    Berman E; Duigou-Osterndorf R; Krown SE; Fanucchi MP; Chou J; Hirsch MS; Clarkson BD; Chou TC
    Blood; 1989 Sep; 74(4):1281-6. PubMed ID: 2765664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
    Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
    Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
    Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of in vitro treatment of chronic myelogenous leukemia cell line, K562 cells, using 4-hydroperoxycyclophosphamide, alpha-interferon and gamma-interferon.
    Lee JT; Park S; Lee JH; Kim BK; Kim NK
    J Korean Med Sci; 1996 Feb; 11(1):26-32. PubMed ID: 8703367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of 3'-azido-3'-deoxythymidine into cellular DNA and its removal in a human leukemic cell line.
    Vazquez-Padua MA; Starnes MC; Cheng YC
    Cancer Commun; 1990; 2(1):55-62. PubMed ID: 2369551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells.
    Hassan HT; Grell S; Borrmann-Danso U; Freund M
    J Interferon Cytokine Res; 1996 Feb; 16(2):139-46. PubMed ID: 8742366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and biochemical implications of combining AZT and AG-331.
    Pressacco J; Mitrovski B; Erlichman C
    Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
    Ma W; Liu F; Yuan L; Zhao C; Chen C
    Oncol Rep; 2020 Jan; 43(1):260-269. PubMed ID: 31746437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
    Chandrasekaran B; Kute TE; Duch DS
    Cancer Chemother Pharmacol; 1995; 35(6):489-95. PubMed ID: 7882457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T; Korycka A
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): its application to autologous bone marrow transplantation for CML.
    Osman Y; Moriyama Y; Shibata A
    Exp Hematol; 1995 May; 23(5):444-52. PubMed ID: 7720816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.
    Pressacco J; Erlichman C
    Biochem Pharmacol; 1993 Dec; 46(11):1989-97. PubMed ID: 8267649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells.
    Zhen YS; Taniki T; Weber G
    Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.
    Estrov Z; Talpaz M; Chou TC; Kurzrock R; Blake M; Gutterman JU
    Leukemia; 1991 Feb; 5(2):101-7. PubMed ID: 2020193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
    Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
    Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.